Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
DOI:
https://doi.org/10.46765/2675-374X.2023v4n1p184Abstract
This summary is intended to update the Brazilian Society of Bone Marrow Transplantation and Cellular Therapy (SBTMO) 2020/1 consensus on HSCT for Acute Myeloid leukemia (AML).
Downloads
Published
02/28/2023
How to Cite
Silla, L. M. da R., Ikoma-Colturato, M. R. V. ., Funke, V. A., Pitombeira, B. S. G. de S. ., Paton, E. J. de A. ., Hamerschlak, N. ., Arantes, A. ., Astigarraga, C. ., Barroso, K. S. N. ., Beltrame, M. P. ., Bettarelo, G. ., Campregher, P. ., Furtado, F. M. ., Souto, E. X. ., Torres, M. A. ., & Duarte, F. B. . (2023). Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 4(1), 184. https://doi.org/10.46765/2675-374X.2023v4n1p184
Issue
Section
Original article
License
Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.